Innate Pharma - Articles and news items

Innate Pharma and Astrazeneca announce co-development and commercialisation collaboration for IPH2201

Industry news / 24 April 2015 / Victoria White

Innate Pharma has signed a co-development and commercialisation agreement with AstraZeneca to accelerate and broaden the development of IPH2201…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+